Fulgent Genetics Cash Conversion Cycle 2011-2026 | FLGT

Annual Cash Conversion Cycle Fulgent Genetics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
42.4	27.6	24.9	19.6	25.4	47	72.6	4	-40.8	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
72.6	-40.8	24.7

Quarterly Cash Conversion Cycle Fulgent Genetics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
45.8	47.2	50.2	-	32.2	29.3	35.4	-	8.29	11.5	22.9	-	33.9	40.3	16.7	13.8	12.4	67.5	23.8	10.2	72.9	659	805	31.6	20.7	31.1	61.7	52.4	50.6	53.4	41.6	10.5	-2.89	-22.7	-47	-67	-37.9	-78	-21.4	56.1	17.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
805	-78	57.6

Cash Conversion Cycle of other stocks in the Diagnostics research industry

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	50.2	-	-6.23 %	$ 30.6 M	Germany
Burning Rock Biotech Limited BNR	149	$ 19.89	10.93 %	$ 211 M	China
Agilent Technologies A	111	$ 120.39	2.46 %	$ 36.6 B	USA
Aspira Women's Health AWH	1.01 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	78.1	-	-13.05 %	$ 7.29 M	USA
Chembio Diagnostics CEMI	111	-	0.22 %	$ 16.8 M	USA
CareDx, Inc CDNA	51.5	$ 17.63	4.75 %	$ 939 M	USA
DermTech DMTK	66.7	-	-11.32 %	$ 2.94 M	USA
Akumin AKU	36.1	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	154	-	-8.98 %	$ 14.8 K	USA
Co-Diagnostics CODX	-2.46 K	$ 1.38	-4.83 %	$ 1.84 M	USA
Exact Sciences Corporation EXAS	42.5	-	-	$ 19.8 B	USA
Accelerate Diagnostics AXDX	364	-	-61.36 %	$ 2.46 M	USA
Castle Biosciences CSTL	45.9	$ 24.37	3.57 %	$ 677 M	USA
Global Cord Blood Corporation CO	184	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	142	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	65	$ 179.31	0.54 %	$ 8.89 B	USA
PRA Health Sciences, Inc. PRAH	1.21 K	-	-	$ 10.7 B	USA
Interpace Biosciences IDXG	62.9	$ 2.2	-	$ 9.73 M	USA
Danaher Corporation DHR	77.5	$ 198.61	1.4 %	$ 142 B	USA
Heska Corporation HSKA	138	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	104	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	142	$ 130.32	2.65 %	$ 20.7 B	USA
Medpace Holdings MEDP	50.4	$ 520.0	3.74 %	$ 15 B	USA
Koninklijke Philips N.V. PHG	89	$ 29.09	1.89 %	$ 20 B	Niderland
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel
Guardant Health GH	79.6	$ 86.4	5.1 %	$ 10.8 B	USA
QIAGEN N.V. QGEN	122	-	-	$ 10.6 B	Niderland
Myriad Genetics MYGN	49.3	$ 4.91	6.97 %	$ 455 M	USA
Anixa Biosciences ANIX	275	$ 2.88	1.05 %	$ 93.5 K	USA
Biomerica BMRA	172	$ 2.1	0.96 %	$ 4.82 M	USA
Senseonics Holdings SENS	36.1	$ 6.75	0.45 %	$ 282 M	USA
ICON Public Limited Company ICLR	62	$ 113.06	2.44 %	$ 9.33 B	Irlanda
NeoGenomics NEO	82.4	$ 8.35	4.38 %	$ 1.07 B	USA
Laboratory Corporation of America Holdings LH	40.3	$ 268.87	1.78 %	$ 22.4 B	USA
Neogen Corporation NEOG	150	$ 9.61	5.14 %	$ 2.08 B	USA
Lantheus Holdings LNTH	97.3	$ 82.74	1.31 %	$ 5.58 B	USA
Quest Diagnostics Incorporated DGX	39.5	$ 194.16	0.65 %	$ 21.6 B	USA
Natera NTRA	81.5	$ 214.64	6.31 %	$ 21.1 B	USA
ENDRA Life Sciences NDRA	-1.24 K	$ 4.96	-4.43 %	$ 3.9 M	USA
Invitae Corporation NVTA	299	-	-	$ 21.2 M	USA
National Research Corporation NRC	29.4	$ 17.04	1.34 %	$ 381 M	USA
Organovo Holdings ONVO	-82.8 K	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	4.66	-	-16.95 %	$ 1.54 M	USA